Login
Toggle navigation
Videos
Categories
Trending
Chorus CCO Ed Hyde and Enable CEO Johnathan Eele discuss the latest industry research on AM on Three.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
JB has been the CEO of Chorus since 2019.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
conversations and now we are sharing them with you every month|Ari Newman,Partner, The Fund Rockies,The Fund
00:10:00
GS Engineering & Construction: Transforming Oman - Customer Testimonial | Chang-Soo Huh - Chairman of GS Engineering & Construction
00:10:00
We invest in anything FAANG companies will buy or build|Ben Ling,General Partner, Bling Capital
00:10:00
Jonah Goldberg: The Constraints of Conservatism
00:00:00
Christopher U. Missling Ph.D. , CEO, Anavex Life Sciences Corp
00:10:00
Selci (Biesse): 'We Need Young Engineers to Keep Up with Technology | Roberto Selci - CEO of Biesse
00:10:00
Insights into Mexico's Fibra Market: A Conversation with Miguel Aliaga, CFO of Fibra Inn|Managing Director,Acadia Realty Trust
00:10:00
Recovery is defined differently at different treatment centers|Joanna Conti,CEO,VistaResearchInc
00:10:00
AI-Powered Mineral Exploration: Sensa's Revolutionary Approach
00:10:00
George W. Bush Reflects on Life After the Presidency and His Presidential Center
00:10:00
Interview with Avesoro: Advancing Exploration and Development at the One-to-One Mining Investment Conference in New York
00:00:00
Cardiologist |Simin Gharib Lee, MD, MBA